Navigation Links
A potential route for human tumor gene therapy
Date:5/20/2008

The type 1 Na+/H+ exchanger (NHE1) is a transmembrane protein found in all eukaryotic cells. One of its functions is to evacuate excessive H+ in the cytoplasm by means of Na+-H+ exchange, resulting in stable intracellular pH value. Inhibition of the upregulation of NHE-1 gene expression in human gastric carcinoma cells can induce intracellular acidification, resulting in apoptosis of tumor cells, which is helpful for the treatment of tumors.

This study, performed by a team led by Professor Hai-Feng Liu, is described in a research article to be published on April 14, 2008 in the World Journal of Gastroenterology.

Previous studies have proven that the significantly higher expression level of NHE1 protein in gastric carcinoma tissues than in normal gastric tissues is closely associated with the genesis and progression of tumors, suggesting that NHE1 can be used as the target in treatment of tumors. However, further studies are needed to know whether the intervention of the antisense NHE1 gene can decrease type 1 Na+/H+ exchange of membranous ion exchange protein in gastric carcinoma cells, and the effects on the biological behaviors of gastric carcinoma cells.

The purpose of transfection of the antisense NHE1 gene into the human gastric carcinoma cell line SGC-7901 is to investigate the effects of antisense therapy targeting the NHE1 gene on the malignant phenotypes of gastric carcinoma cells. The results indicate NHE1 genes are among the important genes in maintaining the phenotypes of the SGC-7901 cell line. NHE1 might be closely associated with the malignant biological behaviors of tumor cells, so the phenotypes of the tumor will be restrained when NHE1 is inhibited.

This is an interesting article examining the effect of inhibiting NHE1 on tumor survival. It would be useful to make clearer in the abstract what NHE1 is. Further research should be done on gene therapy for gastric carcinomas.


'/>"/>

Contact: Jing Zhu
wjg@wjgnet.com
86-105-908-0039
World Journal of Gastroenterology
Source:Eurekalert

Page: 1

Related medicine news :

1. High Growth Potential for Carotid Stent and Thoracic Aortic Stent Graft Markets
2. Phase 3 GATTEX results presented at DDW highlight potential new treatment in short bowel syndrome
3. Estimated 3.2 million Burmese potentially affected by cyclone
4. Most Baby Boomers are Financially Unprepared for a Potential Disability
5. New report: Arthritis is a potential barrier to physical activity for adults with diabetes
6. Improving anxiety treatment through the help of brain imaging: A potential future treatment strategy
7. Preliminary Results from Phase 2 Genzyme Study Highlight Potential of Novel Oral Compound for Gaucher Disease
8. Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted
9. Potential viral therapy weapon for difficult cancers is safe and effective in study
10. Penn researchers find potential in yeast for selecting Lou Gehrigs disease drugs
11. Minnesota partnership advances potential MS therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... , ... January 19, 2017 , ... ... by the American Board of Dermatology and fellowship trained Mohs and cosmetic surgeon. ... Institutes of Health, Dr. Li completed his internship in internal medicine at the ...
(Date:1/19/2017)... ... January 19, 2017 , ... In 2009, Carol ... that resulted in severe facial disfiguration. After four frightening years of isolation and ... UCLA Medical Center, who removed the substances in a partial facial transplant through ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... and privacy panel system. , The Tranquility privacy panel system was designed ... office environment. Tranquility panels help reduce noise and provide the visual privacy required ...
(Date:1/19/2017)... ... , ... Sam & Associates Insurance Agency, a full service firm providing asset ... Bay Area, is launching a charity drive to raise awareness of heart disease risk ... primary killer of adult men and women in America, and is responsible for over ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... agency which serves Lawrenceville, New Jersey and the surrounding area, is inaugurating ... lateral sclerosis (ALS), more commonly known as Lou Gehrig's disease or motor neurone ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... , Jan. 18, 2017 The Philadelphia Pediatric Medical ... developing medical devices for children. The Consortium chose ... seed grants of $50,000 each. The devices under ... nerve signals, a hand-operated rapid blood delivery system for emergency ... babies. ...
(Date:1/18/2017)...   Regenicin, Inc. (OTC Bulletin Board: ... development and commercialization of regenerative cell therapies to restore ... the Company,s operating results for 2016 and an outline ... Company described in its recent 10-K filing with the ... The Company,s contract laboratory completed its evaluation of NovaDerm┬«, ...
(Date:1/18/2017)... 2017  Dermata Therapeutics, LLC, a biotechnology company ... variety of dermatological diseases, announces dosing the first ... Phase 2 acne rosacea study. DMT210 is a ... cytokines in the skin responsible for the inflammation ... This clinical trial, DMT210-003, is a 12-week, ...
Breaking Medicine Technology: